tiprankstipranks
Advertisement
Advertisement

CGON Stock Latest News

CG Oncology Shareholders Back Directors and Governance Proposals
Company AnnouncementsCG Oncology Shareholders Back Directors and Governance Proposals
12d ago
8K
CGON
Oncolytics promotes John McAdory to COO
PremiumThe Fly
Oncolytics promotes John McAdory to COO
19d ago
CGON
ONCY
Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
PremiumRatings
Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
25d ago
CGON
CG Oncology announces departure of president, COO Ambaw Bellete
PremiumThe Fly
CG Oncology announces departure of president, COO Ambaw Bellete
26d ago
CGON
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
PremiumThe Fly
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
26d ago
CGON
CG Oncology Reshapes Executive Team Amid Leadership Transition
PremiumCompany AnnouncementsCG Oncology Reshapes Executive Team Amid Leadership Transition
26d ago
8K
CGON
CG Oncology initiated with a Peer Perform at Wolfe Research
Premium
The Fly
CG Oncology initiated with a Peer Perform at Wolfe Research
1M ago
CGON
Buy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
1M ago
CGON
CG Oncology reports first results from CORE-008 Cohort CX
PremiumThe Fly
CG Oncology reports first results from CORE-008 Cohort CX
1M ago
CGON
CG Oncology price target raised to $82 from $77 at Truist
PremiumThe Fly
CG Oncology price target raised to $82 from $77 at Truist
1M ago
CGON
CG Oncology price target raised to $81 from $79 at RBC Capital
PremiumThe Fly
CG Oncology price target raised to $81 from $79 at RBC Capital
1M ago
CGON
CG Oncology price target raised to $80 from $77 at Wedbush
PremiumThe Fly
CG Oncology price target raised to $80 from $77 at Wedbush
1M ago
CGON
CG Oncology price target raised to $96 from $91 at JPMorgan
PremiumThe FlyCG Oncology price target raised to $96 from $91 at JPMorgan
1M ago
CGON
CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
Premium
Ratings
CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
1M ago
CGON
CG Oncology price target lowered to $83 from $84 at BofA
Premium
The Fly
CG Oncology price target lowered to $83 from $84 at BofA
1M ago
CGON
Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
PremiumRatings
Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
1M ago
CGON
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
PremiumRatings
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
1M ago
CGON
CG Oncology reports Q1 EPS (71c), consensus (54c)
PremiumThe Fly
CG Oncology reports Q1 EPS (71c), consensus (54c)
1M ago
CGON
CG Oncology price target raised to $79 from $73 at RBC Capital
PremiumThe Fly
CG Oncology price target raised to $79 from $73 at RBC Capital
2M ago
CGON
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
CGON
SMMT
JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
Premium
The Fly
JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
2M ago
JNJ
CGON
CG Oncology price target raised to $84 from $72 at BofA
Premium
The Fly
CG Oncology price target raised to $84 from $72 at BofA
2M ago
CGON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >